Global Immune Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

November 2024 | 89 pages | ID: G8ACAB4229DBEN
GlobalInfoResearch

Abstracts

According to our latest research, the global Immune Cell Therapy market size will reach USD 14740 million in 2030, growing at a CAGR of 22.6% over the analysis period.

Immune Cell Therapy is a medical treatment approach that involves modifying a patient's own immune cells, typically T cells, to enhance their ability to recognize and attack cancer cells or other diseases.

The Immune Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Market segmentation

Immune Cell Therapy market is split by Type and by Application. For the period 2024-2030, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

• T Cell Therapy
• Natural Killer (NK) Cell Therapy
• Other

Market segment by Application, can be divided into

• Stomach Cancer
• Lung Cancer
• Colorectal Cancer
• Esophageal Cancer
• Pancreatic Cancer
• Other

Market segment by players, this report covers

• Adaptimmune
• Altor Bioscience Corporation
• Cellectis
• Juno Therapeutics
• Kite Pharma
• Novartis
• Takara Bio
• Unum Therapeutics

Market segment by regions, regional analysis covers

• North America
• Europe
• Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
• South America
• Middle East & Africa

The content of the study subjects, includes a total of 8 chapters:

Chapter 1, to describe Immune Cell Therapy product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Immune Cell Therapy, with recent developments and future plans

Chapter 3, the Immune Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4, to break the market size data at the region level, with key companies in the key region and Immune Cell Therapy market forecast, by regions, with revenue, from 2024 to 2030.

Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2024 to 2030.

Chapter 7 and 8, to describe Immune Cell Therapy research findings and conclusion, appendix and data source.

Contents

1 MARKET OVERVIEW

1.1 Product Overview and Scope of Immune Cell Therapy
1.2 Classification of Immune Cell Therapy by Type
  1.2.1 Overview: Global Immune Cell Therapy Market Size by Type: 2024 Versus 2030
  1.2.2 Global Immune Cell Therapy Revenue Market Share by Type in 2030
  1.2.3 T Cell Therapy
  1.2.4 Natural Killer (NK) Cell Therapy
  1.2.5 Other
1.3 Global Immune Cell Therapy Market by Application
  1.3.1 Overview: Global Immune Cell Therapy Market Size by Application: 2024 Versus 2030
  1.3.2 Stomach Cancer
  1.3.3 Lung Cancer
  1.3.4 Colorectal Cancer
  1.3.5 Esophageal Cancer
  1.3.6 Pancreatic Cancer
  1.3.7 Other
1.4 Global Immune Cell Therapy Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
  1.5.1 Immune Cell Therapy Market Drivers
  1.5.2 Immune Cell Therapy Market Restraints
  1.5.3 Immune Cell Therapy Trends Analysis

2 COMPANY PROFILES

2.1 Adaptimmune
  2.1.1 Adaptimmune Details
  2.1.2 Adaptimmune Major Business
  2.1.3 Adaptimmune Immune Cell Therapy Product and Solutions
  2.1.4 Adaptimmune Recent Developments and Future Plans
2.2 Altor Bioscience Corporation
  2.2.1 Altor Bioscience Corporation Details
  2.2.2 Altor Bioscience Corporation Major Business
  2.2.3 Altor Bioscience Corporation Immune Cell Therapy Product and Solutions
  2.2.4 Altor Bioscience Corporation Recent Developments and Future Plans
2.3 Cellectis
  2.3.1 Cellectis Details
  2.3.2 Cellectis Major Business
  2.3.3 Cellectis Immune Cell Therapy Product and Solutions
  2.3.4 Cellectis Recent Developments and Future Plans
2.4 Juno Therapeutics
  2.4.1 Juno Therapeutics Details
  2.4.2 Juno Therapeutics Major Business
  2.4.3 Juno Therapeutics Immune Cell Therapy Product and Solutions
  2.4.4 Juno Therapeutics Recent Developments and Future Plans
2.5 Kite Pharma
  2.5.1 Kite Pharma Details
  2.5.2 Kite Pharma Major Business
  2.5.3 Kite Pharma Immune Cell Therapy Product and Solutions
  2.5.4 Kite Pharma Recent Developments and Future Plans
2.6 Novartis
  2.6.1 Novartis Details
  2.6.2 Novartis Major Business
  2.6.3 Novartis Immune Cell Therapy Product and Solutions
  2.6.4 Novartis Recent Developments and Future Plans
2.7 Takara Bio
  2.7.1 Takara Bio Details
  2.7.2 Takara Bio Major Business
  2.7.3 Takara Bio Immune Cell Therapy Product and Solutions
  2.7.4 Takara Bio Recent Developments and Future Plans
2.8 Unum Therapeutics
  2.8.1 Unum Therapeutics Details
  2.8.2 Unum Therapeutics Major Business
  2.8.3 Unum Therapeutics Immune Cell Therapy Product and Solutions
  2.8.4 Unum Therapeutics Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Immune Cell Therapy Revenue and Share by Players (2024 & 2030)
3.2 Immune Cell Therapy Players Head Office, Products and Services Provided
3.3 Immune Cell Therapy Mergers & Acquisitions
3.4 Immune Cell Therapy New Entrants and Expansion Plans

4 GLOBAL IMMUNE CELL THERAPY FORECAST BY REGION

4.1 Global Immune Cell Therapy Market Size by Region: 2024 VS 2030
4.2 Global Immune Cell Therapy Market Size by Region, (2024-2030)
4.3 North America
  4.3.1 Key Companies of Immune Cell Therapy in North America
  4.3.2 Current Situation and Forecast of Immune Cell Therapy in North America
  4.3.3 North America Immune Cell Therapy Market Size and Prospect (2024-2030)
4.4 Europe
  4.4.1 Key Companies of Immune Cell Therapy in Europe
  4.4.2 Current Situation and Forecast of Immune Cell Therapy in Europe
  4.4.3 Europe Immune Cell Therapy Market Size and Prospect (2024-2030)
4.5 Asia-Pacific
  4.5.1 Key Companies of Immune Cell Therapy in Asia-Pacific
  4.5.2 Current Situation and Forecast of Immune Cell Therapy in Asia-Pacific
  4.5.3 Asia-Pacific Immune Cell Therapy Market Size and Prospect (2024-2030)
  4.5.4 China
  4.5.5 Japan
  4.5.6 South Korea
4.6 South America
  4.6.1 Key Companies of Immune Cell Therapy in South America
  4.6.2 Current Situation and Forecast of Immune Cell Therapy in South America
  4.6.3 South America Immune Cell Therapy Market Size and Prospect (2024-2030)
4.7 Middle East & Africa
  4.7.1 Key Companies of Immune Cell Therapy in Middle East & Africa
  4.7.2 Current Situation and Forecast of Immune Cell Therapy in Middle East & Africa
  4.7.3 Middle East & Africa Immune Cell Therapy Market Size and Prospect (2024-2030)

5 MARKET SIZE SEGMENT BY TYPE

5.1 Global Immune Cell Therapy Market Forecast by Type (2024-2030)
5.2 Global Immune Cell Therapy Market Share Forecast by Type (2024-2030)

6 MARKET SIZE SEGMENT BY APPLICATION

6.1 Global Immune Cell Therapy Market Forecast by Application (2024-2030)
6.2 Global Immune Cell Therapy Market Share Forecast by Application (2024-2030)

7 RESEARCH FINDINGS AND CONCLUSION

8 APPENDIX

8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Immune Cell Therapy Revenue by Type, (USD Million), 2024 VS 2030
Table 2. Global Immune Cell Therapy Revenue by Application, (USD Million), 2024 VS 2030
Table 3. Adaptimmune Corporate Information, Head Office, and Major Competitors
Table 4. Adaptimmune Major Business
Table 5. Adaptimmune Immune Cell Therapy Product and Solutions
Table 6. Altor Bioscience Corporation Corporate Information, Head Office, and Major Competitors
Table 7. Altor Bioscience Corporation Major Business
Table 8. Altor Bioscience Corporation Immune Cell Therapy Product and Solutions
Table 9. Cellectis Corporate Information, Head Office, and Major Competitors
Table 10. Cellectis Major Business
Table 11. Cellectis Immune Cell Therapy Product and Solutions
Table 12. Juno Therapeutics Corporate Information, Head Office, and Major Competitors
Table 13. Juno Therapeutics Major Business
Table 14. Juno Therapeutics Immune Cell Therapy Product and Solutions
Table 15. Kite Pharma Corporate Information, Head Office, and Major Competitors
Table 16. Kite Pharma Major Business
Table 17. Kite Pharma Immune Cell Therapy Product and Solutions
Table 18. Novartis Corporate Information, Head Office, and Major Competitors
Table 19. Novartis Major Business
Table 20. Novartis Immune Cell Therapy Product and Solutions
Table 21. Takara Bio Corporate Information, Head Office, and Major Competitors
Table 22. Takara Bio Major Business
Table 23. Takara Bio Immune Cell Therapy Product and Solutions
Table 24. Unum Therapeutics Corporate Information, Head Office, and Major Competitors
Table 25. Unum Therapeutics Major Business
Table 26. Unum Therapeutics Immune Cell Therapy Product and Solutions
Table 27. Global Immune Cell Therapy Revenue (USD Million) by Players (2024 & 2030)
Table 28. Global Immune Cell Therapy Revenue Share by Players (2024 & 2030)
Table 29. Immune Cell Therapy Players Head Office, Products and Services Provided
Table 30. Immune Cell Therapy Mergers & Acquisitions in the Past Five Years
Table 31. Immune Cell Therapy New Entrants and Expansion Plans
Table 32. Global Market Immune Cell Therapy Revenue (USD Million) Comparison by Region (2024 VS 2030)
Table 33. Global Immune Cell Therapy Revenue Market Share by Region (2024-2030)
Table 34. Key Companies of Immune Cell Therapy in North America
Table 35. Current Situation and Forecast of Immune Cell Therapy in North America
Table 36. Key Companies of Immune Cell Therapy in Europe
Table 37. Current Situation and Forecast of Immune Cell Therapy in Europe
Table 38. Key Companies of Immune Cell Therapy in Asia-Pacific
Table 39. Current Situation and Forecast of Immune Cell Therapy in Asia-Pacific
Table 40. Key Companies of Immune Cell Therapy in China
Table 41. Key Companies of Immune Cell Therapy in Japan
Table 42. Key Companies of Immune Cell Therapy in South Korea
Table 43. Key Companies of Immune Cell Therapy in South America
Table 44. Current Situation and Forecast of Immune Cell Therapy in South America
Table 45. Key Companies of Immune Cell Therapy in Middle East & Africa
Table 46. Current Situation and Forecast of Immune Cell Therapy in Middle East & Africa
Table 47. Global Immune Cell Therapy Revenue Forecast by Type (2024-2030)
Table 48. Global Immune Cell Therapy Revenue Forecast by Application (2024-2030)

List Of Figures

LIST OF FIGURES

Figure 1. Immune Cell Therapy Picture
Figure 2. Global Immune Cell Therapy Revenue Market Share by Type in 2030
Figure 3. T Cell Therapy
Figure 4. Natural Killer (NK) Cell Therapy
Figure 5. Other
Figure 6. Immune Cell Therapy Revenue Market Share by Application in 2030
Figure 7. Stomach Cancer Picture
Figure 8. Lung Cancer Picture
Figure 9. Colorectal Cancer Picture
Figure 10. Esophageal Cancer Picture
Figure 11. Pancreatic Cancer Picture
Figure 12. Other Picture
Figure 13. Global Immune Cell Therapy Market Size, (USD Million): 2024 VS 2030
Figure 14. Global Immune Cell Therapy Revenue and Forecast (2024-2030) & (USD Million)
Figure 15. Immune Cell Therapy Market Drivers
Figure 16. Immune Cell Therapy Market Restraints
Figure 17. Immune Cell Therapy Market Trends
Figure 18. Adaptimmune Recent Developments and Future Plans
Figure 19. Altor Bioscience Corporation Recent Developments and Future Plans
Figure 20. Cellectis Recent Developments and Future Plans
Figure 21. Juno Therapeutics Recent Developments and Future Plans
Figure 22. Kite Pharma Recent Developments and Future Plans
Figure 23. Novartis Recent Developments and Future Plans
Figure 24. Takara Bio Recent Developments and Future Plans
Figure 25. Unum Therapeutics Recent Developments and Future Plans
Figure 26. Global Immune Cell Therapy Revenue Market Share by Region (2024-2030)
Figure 27. Global Immune Cell Therapy Revenue Market Share by Region in 2030
Figure 28. North America Immune Cell Therapy Revenue (USD Million) and Growth Rate (2024-2030)
Figure 29. Europe Immune Cell Therapy Revenue (USD Million) and Growth Rate (2024-2030)
Figure 30. Asia-Pacific Immune Cell Therapy Revenue (USD Million) and Growth Rate (2024-2030)
Figure 31. South America Immune Cell Therapy Revenue (USD Million) and Growth Rate (2024-2030)
Figure 32. Middle East & Africa Immune Cell Therapy Revenue (USD Million) and Growth Rate (2024-2030)
Figure 33. Global Immune Cell Therapy Market Share Forecast by Type (2024-2030)
Figure 34. Global Immune Cell Therapy Market Share Forecast by Application (2024-2030)
Figure 35. Methodology
Figure 36. Research Process and Data Source